JP2014520787A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520787A5 JP2014520787A5 JP2014517822A JP2014517822A JP2014520787A5 JP 2014520787 A5 JP2014520787 A5 JP 2014520787A5 JP 2014517822 A JP2014517822 A JP 2014517822A JP 2014517822 A JP2014517822 A JP 2014517822A JP 2014520787 A5 JP2014520787 A5 JP 2014520787A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11173067 | 2011-07-07 | ||
| EP11173067.7 | 2011-07-07 | ||
| PCT/EP2012/063249 WO2013004818A1 (en) | 2011-07-07 | 2012-07-06 | Darunavir combination formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520787A JP2014520787A (ja) | 2014-08-25 |
| JP2014520787A5 true JP2014520787A5 (enExample) | 2015-08-13 |
| JP6122427B2 JP6122427B2 (ja) | 2017-04-26 |
Family
ID=46551505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517822A Active JP6122427B2 (ja) | 2011-07-07 | 2012-07-06 | ダルナビル複合製剤 |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US20140142070A1 (enExample) |
| EP (1) | EP2729130B1 (enExample) |
| JP (1) | JP6122427B2 (enExample) |
| KR (1) | KR102058097B1 (enExample) |
| CN (1) | CN103826616B (enExample) |
| AU (1) | AU2012280198B2 (enExample) |
| BR (1) | BR112014000290B1 (enExample) |
| CA (1) | CA2838659C (enExample) |
| CY (1) | CY1121999T1 (enExample) |
| DK (1) | DK2729130T3 (enExample) |
| EA (1) | EA026587B1 (enExample) |
| ES (1) | ES2651212T3 (enExample) |
| HR (1) | HRP20171889T1 (enExample) |
| HU (1) | HUE035241T2 (enExample) |
| IL (1) | IL229933A (enExample) |
| LT (1) | LT2729130T (enExample) |
| MX (1) | MX343689B (enExample) |
| NO (1) | NO2729130T3 (enExample) |
| PL (1) | PL2729130T3 (enExample) |
| PT (1) | PT2729130T (enExample) |
| RS (1) | RS56667B1 (enExample) |
| SI (1) | SI2729130T1 (enExample) |
| SM (1) | SMT201700574T1 (enExample) |
| WO (1) | WO2013004818A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2729130T (pt) | 2011-07-07 | 2017-12-13 | Gilead Sciences Inc | Formulações de combinação de darunavir |
| WO2013130766A1 (en) * | 2012-03-01 | 2013-09-06 | Gilead Sciences, Inc. | Spray dried formulations |
| NZ709260A (en) | 2012-12-21 | 2016-07-29 | Gilead Sciences Inc | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use |
| CN113546052A (zh) | 2015-11-09 | 2021-10-26 | 吉利德科学公司 | 治疗人免疫缺陷病毒的治疗组合物 |
| BR112019002132A2 (pt) | 2016-08-08 | 2019-05-14 | Hetero Labs Limited | composições anti-retrovirais |
| WO2018029566A1 (en) * | 2016-08-08 | 2018-02-15 | Hetero Labs Limited | A high drug loaded tablet composition for treating hiv |
| BR112019002120A2 (pt) * | 2016-08-08 | 2019-05-14 | Hetero Labs Limited | composição anti-retroviral de várias classes |
| EP3518935A1 (en) * | 2016-09-27 | 2019-08-07 | Gilead Sciences, Inc. | Therapeutic compositions for treatment of human immunodeficiency virus |
| BR112020000842A2 (pt) | 2017-07-20 | 2020-07-21 | Janssen Sciences Ireland Unlimited Company | composições e métodos para tratamento do hiv |
| US20200101093A1 (en) | 2018-09-28 | 2020-04-02 | Janssen Sciences Ireland Unlimited Company | Methods of Treating and Preventing Neuropsychiatric and/or Neurocognitive Complications in Patients Infected with HIV |
| US20210290590A1 (en) | 2020-03-13 | 2021-09-23 | Janssen Sciences Ireland Unlimited Company | Methods of treating subjects infected with hiv |
| CN119700779B (zh) * | 2024-11-28 | 2025-11-04 | 安徽贝克生物制药有限公司 | 一种达芦那韦和考比司他复合片剂及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995006030A1 (en) | 1993-08-24 | 1995-03-02 | G.D. Searle & Co. | Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors |
| US5968942A (en) | 1992-08-25 | 1999-10-19 | G. D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| AU771780B2 (en) | 1998-06-23 | 2004-04-01 | Board Of Trustees Of The University Of Illinois, The | Fitness assay and associated methods |
| AR037797A1 (es) | 2001-12-12 | 2004-12-01 | Tibotec Pharm Ltd | Combinacion de inhibidores de proteasa dependientes del citocromo p450 |
| AU2003271740B2 (en) | 2002-05-16 | 2010-05-13 | Janssen R&D Ireland | Pseudopolymorphic forms of a HIV protease inhibitor |
| TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
| MX339668B (es) | 2006-05-30 | 2016-06-02 | Janssen Pharmaceutica N V * | Compuestos de piridil amida sustituidos como moduladores del receptor h3 de la histamina. |
| US20080039428A1 (en) * | 2006-06-29 | 2008-02-14 | Panacos Pharmaceuticals, Inc. | Antiretroviral combination therapy |
| PL2049506T5 (pl) | 2006-07-07 | 2024-09-09 | Gilead Sciences, Inc. | Modulatory farmakokinetycznych właściwości leków |
| MX2009004439A (es) * | 2006-10-25 | 2009-05-11 | Mcneil Ppc Inc | Composicion de ibuprofeno. |
| EP3150586B1 (en) | 2007-02-23 | 2020-01-08 | Gilead Sciences, Inc. | Modulators of pharmacokinetic properties of therapeutics |
| RU2010102067A (ru) * | 2007-06-25 | 2011-07-27 | Тиботек Фармасьютикалз (Ie) | Комбинированные композиции, включающие дарунавир и этравирин |
| AR069539A1 (es) * | 2007-07-25 | 2010-02-03 | Tibotec Pharm Ltd | Avances respecto de las formulaciones de comprimidos contra el vih |
| CA2706328C (en) | 2007-11-20 | 2016-04-19 | Janssen Pharmaceutica N.V. | Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor |
| PA8809601A1 (es) * | 2007-12-24 | 2009-07-23 | Cipla Ltd | Combinación anti-retroviral |
| EP2296633B1 (en) * | 2008-05-02 | 2015-09-30 | Gilead Sciences, Inc. | The use of solid carrier particles to improve the processability of a pharmaceutical agent |
| NZ594214A (en) * | 2009-02-06 | 2013-05-31 | Gilead Sciences Inc | Tablets comprising cobicistat, elvitegravir, emtricitabine and tenofovir disoproxil fumarate for combination therapy |
| PT2477992T (pt) * | 2009-09-17 | 2017-03-20 | Mylan Laboratories Ltd | Processos para a preparação de darunavir e a forma amorfa do mesmo |
| US20130195978A1 (en) | 2010-05-10 | 2013-08-01 | Hetero Research Foundation | Darunavir Compositions |
| PT2729130T (pt) | 2011-07-07 | 2017-12-13 | Gilead Sciences Inc | Formulações de combinação de darunavir |
| HUE030341T2 (en) | 2011-07-07 | 2017-05-29 | Janssen Sciences Ireland Uc | Darunavir preparations |
| AU2012327170A1 (en) | 2012-02-03 | 2013-08-22 | Gilead Sciences, Inc. | Therapeutic compounds |
| JP2018502118A (ja) | 2015-01-03 | 2018-01-25 | マイラン・ラボラトリーズ・リミテッドＭｙｌａｎ Ｌａｂｏｒａｔｏｒｉｅｓ Ｌｉｍｉｔｅｄ | 非晶質ヘミフマル酸テノホビルアラフェナミドおよびその予備混合物を調製するプロセス |
-
2012
- 2012-07-06 PT PT127380608T patent/PT2729130T/pt unknown
- 2012-07-06 KR KR1020147000092A patent/KR102058097B1/ko active Active
- 2012-07-06 HU HUE12738060A patent/HUE035241T2/en unknown
- 2012-07-06 SM SM20170574T patent/SMT201700574T1/it unknown
- 2012-07-06 BR BR112014000290-8A patent/BR112014000290B1/pt active IP Right Grant
- 2012-07-06 EP EP12738060.8A patent/EP2729130B1/en active Active
- 2012-07-06 SI SI201231141T patent/SI2729130T1/en unknown
- 2012-07-06 CA CA2838659A patent/CA2838659C/en active Active
- 2012-07-06 DK DK12738060.8T patent/DK2729130T3/en active
- 2012-07-06 EA EA201490222A patent/EA026587B1/ru unknown
- 2012-07-06 US US14/131,282 patent/US20140142070A1/en not_active Abandoned
- 2012-07-06 WO PCT/EP2012/063249 patent/WO2013004818A1/en not_active Ceased
- 2012-07-06 PL PL12738060T patent/PL2729130T3/pl unknown
- 2012-07-06 RS RS20171244A patent/RS56667B1/sr unknown
- 2012-07-06 JP JP2014517822A patent/JP6122427B2/ja active Active
- 2012-07-06 ES ES12738060.8T patent/ES2651212T3/es active Active
- 2012-07-06 NO NO12738060A patent/NO2729130T3/no unknown
- 2012-07-06 LT LTEP12738060.8T patent/LT2729130T/lt unknown
- 2012-07-06 MX MX2013015199A patent/MX343689B/es active IP Right Grant
- 2012-07-06 CN CN201280033554.0A patent/CN103826616B/zh active Active
- 2012-07-06 HR HRP20171889TT patent/HRP20171889T1/hr unknown
- 2012-07-06 AU AU2012280198A patent/AU2012280198B2/en active Active
-
2013
- 2013-12-17 IL IL229933A patent/IL229933A/en active IP Right Grant
-
2017
- 2017-12-05 CY CY20171101267T patent/CY1121999T1/el unknown
-
2019
- 2019-11-27 US US16/697,888 patent/US11654150B2/en active Active
-
2023
- 2023-05-05 US US18/313,266 patent/US20230302024A1/en active Pending